참고문헌
- Abdul-Hay, S.O., Kang, D., McBride, M., Li, L., Zhao, J., and Leissring, M.A. (2011). Deletion of insulin-degrading enzyme elicits antipodal, agedependent effects on glucose and insulin tolerance. PLoS One 6, e20818. https://doi.org/10.1371/journal.pone.0020818
- Bojsen-Moller, K.N., Lundsgaard, A.M., Madsbad, S., Kiens, B., and Holst, J.J. (2018). Hepatic insulin clearance in regulation of systemic insulin concentrations-role of carbohydrate and energy availability. Diabetes 67, 2129-2136. https://doi.org/10.2337/db18-0539
- Bonnefond, A., Froguel, P., and Vaxillaire, M. (2010). The emerging genetics of type 2 diabetes. Trends Mol. Med. 16, 407-416. https://doi.org/10.1016/j.molmed.2010.06.004
- Bonnet, M.C., Preukschat, D., Welz, P.S., van Loo, G., Ermolaeva, M.A., Bloch, W., Haase, I., and Pasparakis, M. (2011). The adaptor protein FADD protects epidermal keratinocytes from necroptosis in vivo and prevents skin inflammation. Immunity 35, 572-582. https://doi.org/10.1016/j.immuni.2011.08.014
- Cao, Y., Jiang, X., Ma, H., Wang, Y., Xue, P., and Liu, Y. (2016). SIRT1 and insulin resistance. J. Diabetes Complications 30, 178-183. https://doi.org/10.1016/j.jdiacomp.2015.08.022
- Cheng, W., Zhang, R., Yao, C., He, L., Jia, K., Yang, B., Du, P., Zhuang, H., Chen, J., Liu, Z., et al. (2014). A critical role of Fas-associated protein with death domain phosphorylation in intracellular reactive oxygen species homeostasis and aging. Antioxid. Redox Signal. 21, 33-45. https://doi.org/10.1089/ars.2013.5390
- Cheng, Z. and White, M.F. (2011). Targeting Forkhead box O1 from the concept to metabolic diseases: lessons from mouse models. Antioxid. Redox Signal. 14, 649-661. https://doi.org/10.1089/ars.2010.3370
- Chinnaiyan, A.M., O'Rourke, K., Tewari, M., and Dixit, V.M. (1995). FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81, 505-512. https://doi.org/10.1016/0092-8674(95)90071-3
- Duckworth, W.C., Bennett, R.G., and Hamel, F.G. (1998). Insulin degradation: progress and potential. Endocr. Rev. 19, 608-624. https://doi.org/10.1210/edrv.19.5.0349
- Eckenrode, S., Marron, M.P., Nicholls, R., Yang, M.C., Yang, J.J., Guida Fonseca, L.C., and She, J.X. (2000). Fine-mapping of the type 1 diabetes locus (IDDM4) on chromosome 11q and evaluation of two candidate genes (FADD and GALN) by affected sibpair and linkage-disequilibrium analyses. Hum. Genet. 106, 14-18. https://doi.org/10.1007/s004399900186
- Hua, Z.C., Sohn, S.J., Kang, C., Cado, D., and Winoto, A. (2003). A function of Fas-associated death domain protein in cell cycle progression localized to a single amino acid at its C-terminal region. Immunity 18, 513-521. https://doi.org/10.1016/S1074-7613(03)00083-9
- Imtiyaz, H.Z., Zhou, X., Zhang, H., Chen, D., Hu, T., and Zhang, J. (2009). The death domain of FADD is essential for embryogenesis, lymphocyte development, and proliferation. J. Biol. Chem. 284, 9917-9926. https://doi.org/10.1074/jbc.M900249200
- Kabra, N.H., Kang, C., Hsing, L.C., Zhang, J., and Winoto, A. (2001). T cell-specific FADD-deficient mice: FADD is required for early T cell development. Proc. Natl. Acad. Sci. U. S. A. 98, 6307-6312. https://doi.org/10.1073/pnas.111158698
- Lee, E.W., Seo, J., Jeong, M., Lee, S., and Song, J. (2012). The roles of FADD in extrinsic apoptosis and necroptosis. BMB Rep. 45, 496-508. https://doi.org/10.5483/BMBRep.2012.45.9.186
- Lu, M., Wan, M., Leavens, K.F., Chu, Q., Monks, B.R., Fernandez, S., Ahima, R.S., Ueki, K., Kahn, C.R., and Birnbaum, M.J. (2012). Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1. Nat. Med. 18, 388-395. https://doi.org/10.1038/nm.2686
- Matsumoto, M., Han, S., Kitamura, T., and Accili, D. (2006). Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism. J. Clin. Invest. 116, 2464-2472.
- Matsumoto, M., Pocai, A., Rossetti, L., Depinho, R.A., and Accili, D. (2007). Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver. Cell Metab. 6, 208-216. https://doi.org/10.1016/j.cmet.2007.08.006
- Matsuyoshi, S., Shimada, K., Nakamura, M., Ishida, E., and Konishi, N. (2006). FADD phosphorylation is critical for cell cycle regulation in breast cancer cells. Br. J. Cancer 94, 532-539. https://doi.org/10.1038/sj.bjc.6602955
- Moriwaki, M., Itoh, N., Miyagawa, J., Yamamoto, K., Imagawa, A., Yamagata, K., Iwahashi, H., Nakajima, H., Namba, M., Nagata, S., et al. (1999). Fas and Fas ligand expression in inflamed islets in pancreas sections of patients with recent-onset type I diabetes mellitus. Diabetologia 42, 1332-1340. https://doi.org/10.1007/s001250051446
- Pirot, P., Cardozo, A.K., and Eizirik, D.L. (2008). Mediators and mechanisms of pancreatic beta-cell death in type 1 diabetes. Arq. Bras. Endocrinol. Metabol. 52, 156-165. https://doi.org/10.1590/S0004-27302008000200003
- Pivovarova, O., Hohn, A., Grune, T., Pfeiffer, A.F., and Rudovich, N. (2016). Insulin-degrading enzyme: new therapeutic target for diabetes and Alzheimer's disease? Ann. Med. 48, 614-624. https://doi.org/10.1080/07853890.2016.1197416
- Pivovarova, O., von Loeffelholz, C., Ilkavets, I., Sticht, C., Zhuk, S., Murahovschi, V., Lukowski, S., Docke, S., Kriebel, J., de las Heras Gala, T., et al. (2015). Modulation of insulin degrading enzyme activity and liver cell proliferation. Cell Cycle 14, 2293-2300. https://doi.org/10.1080/15384101.2015.1046647
- Pyo, J.O., Jang, M.H., Kwon, Y.K., Lee, H.J., Jun, J.I., Woo, H.N., Cho, D.H., Choi, B., Lee, H., Kim, J.H., et al. (2005). Essential roles of Atg5 and FADD in autophagic cell death: dissection of autophagic cell death into vacuole formation and cell death. J. Biol. Chem. 280, 20722-20729. https://doi.org/10.1074/jbc.M413934200
- Rezende, L.F., Camargo, R.L., Branco, R.C., Cappelli, A.P., Boschero, A.C., and Carneiro, E.M. (2014). Reduced insulin clearance and lower insulindegrading enzyme expression in the liver might contribute to the thrifty phenotype of protein-restricted mice. Br. J. Nutr. 112, 900-907. https://doi.org/10.1017/S0007114514001238
- Rubenstein, A.H., Pottenger, L.A., Mako, M., Getz, G.S., and Steiner, D.F. (1972). The metabolism of proinsulin and insulin by the liver. J. Clin. Invest. 51, 912-921. https://doi.org/10.1172/JCI106886
- Shen, Y., Joachimiak, A., Rosner, M.R., and Tang, W.J. (2006). Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism. Nature 443, 870-874. https://doi.org/10.1038/nature05143
- Shimada, K., Nakamura, M., Ishida, E., and Konishi, N. (2006). Molecular roles of MAP kinases and FADD phosphorylation in prostate cancer. Histol. Histopathol. 21, 415-422.
- Silva, D.G., Petrovsky, N., Socha, L., Slattery, R., Gatenby, P., and Charlton, B. (2003). Mechanisms of accelerated immune-mediated diabetes resulting from islet beta cell expression of a Fas ligand transgene. J. Immunol. 170, 4996-5002. https://doi.org/10.4049/jimmunol.170.10.4996
- Sin, T.K., Yung, B.Y., and Siu, P.M. (2015). Modulation of SIRT1-Foxo1 signaling axis by resveratrol: implications in skeletal muscle aging and insulin resistance. Cell. Physiol. Biochem. 35, 541-552. https://doi.org/10.1159/000369718
- Steneberg, P., Bernardo, L., Edfalk, S., Lundberg, L., Backlund, F., Ostenson, C.G., and Edlund, H. (2013). The type 2 diabetes-associated gene ide is required for insulin secretion and suppression of alpha-synuclein levels in beta-cells. Diabetes 62, 2004-2014. https://doi.org/10.2337/db12-1045
- Strandmark, K.M. and Hallberg, L.R.M. (2007). The origin of workplace bullying: experiences from the perspective of bully victims in the public service sector. J. Nurs. Manag. 15, 332-341. https://doi.org/10.1111/j.1365-2834.2007.00662.x
- Thomas, L.R., Henson, A., Reed, J.C., Salsbury, F.R., and Thorburn, A. (2004). Direct binding of Fas-associated death domain (FADD) to the tumor necrosis factor-related apoptosis-inducing ligand receptor DR5 is regulated by the death effector domain of FADD. J. Biol. Chem. 279, 32780-32785. https://doi.org/10.1074/jbc.M401680200
- Titchenell, P.M., Lazar, M.A., and Birnbaum, M.J. (2017). Unraveling the regulation of hepatic metabolism by insulin. Trends Endocrinol. Metab. 28, 497-505. https://doi.org/10.1016/j.tem.2017.03.003
- Valera Mora, M.E., Scarfone, A., Calvani, M., Greco, A.V., and Mingrone, G. (2003). Insulin clearance in obesity. J. Am. Coll. Nutr. 22, 487-493. https://doi.org/10.1080/07315724.2003.10719326
- Vettorazzi, J.F., Kurauti, M.A., Soares, G.M., Borck, P.C., Ferreira, S.M., Branco, R.C.S., Michelone, L.S.L., Boschero, A.C., Junior, J.M.C., and Carneiro, E.M. (2017). Bile acid TUDCA improves insulin clearance by increasing the expression of insulin-degrading enzyme in the liver of obese mice. Sci. Rep. 7, 14876. https://doi.org/10.1038/s41598-017-13974-0
- Villa-Perez, P., Merino, B., Fernandez-Diaz, C.M., Cidad, P., Lobaton, C.D., Moreno, A., Muturi, H.T., Ghadieh, H.E., Najjar, S.M., Leissring, M.A., et al. (2018). Liver-specific ablation of insulin-degrading enzyme causes hepatic insulin resistance and glucose intolerance, without affecting insulin clearance in mice. Metabolism 88, 1-11. https://doi.org/10.1016/j.metabol.2018.08.001
- Welz, P.S., Wullaert, A., Vlantis, K., Kondylis, V., Fernandez-Majada, V., Ermolaeva, M., Kirsch, P., Sterner-Kock, A., van Loo, G., and Pasparakis, M. (2011). FADD prevents RIP3-mediated epithelial cell necrosis and chronic intestinal inflammation. Nature 477, 330-334. https://doi.org/10.1038/nature10273
- Xiong, S., Salazar, G., Patrushev, N., and Alexander, R.W. (2011). FoxO1 mediates an autofeedback loop regulating SIRT1 expression. J. Biol. Chem. 286, 5289-5299. https://doi.org/10.1074/jbc.M110.163667
- Yao, C., Zhuang, H., Cheng, W., Lin, Y., Du, P., Yang, B., Huang, X., Chen, S., Hu, Q., and Hua, Z.C. (2015). FADD phosphorylation impaired islet morphology and function. J. Cell. Physiol. 230, 1448-1456. https://doi.org/10.1002/jcp.24885
- Yao, C., Zhuang, H., Du, P., Cheng, W., Yang, B., Guan, S., Hu, Y., Zhu, D., Christine, M., Shi, L., et al. (2013). Role of Fas-associated death domaincontaining protein (FADD) phosphorylation in regulating glucose homeostasis: from proteomic discovery to physiological validation. Mol. Cell. Proteomics 12, 2689-2700. https://doi.org/10.1074/mcp.M113.029306
- Zhang, L., Ding, Q., Wang, P., and Wang, Z. (2013). An upstream promoter element blocks the reverse transcription of the mouse insulin-degrading enzyme gene. Biochem. Biophys. Res. Commun. 430, 26-31. https://doi.org/10.1016/j.bbrc.2012.11.052
- Zhang, W., Patil, S., Chauhan, B., Guo, S., Powell, D.R., Le, J., Klotsas, A., Matika, R., Xiao, X., Franks, R., et al. (2006). FoxO1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression. J. Biol. Chem. 281, 10105-10117. https://doi.org/10.1074/jbc.M600272200
- Zhuang, H., Wang, X., Zha, D., Gan, Z., Cai, F., Du, P., Yang, Y., Yang, B., Zhang, X., Yao, C., et al. (2016). FADD is a key regulator of lipid metabolism. EMBO Mol. Med. 8, 895-918. https://doi.org/10.15252/emmm.201505924
피인용 문헌
- Modulation of Insulin Sensitivity by Insulin-Degrading Enzyme vol.9, pp.1, 2021, https://doi.org/10.3390/biomedicines9010086